Global Antihypertensive Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Antihypertensive market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Antihypertensive market size is estimated to be worth US$ 19810 million in 2021 and is forecast to a readjusted size of USD 22820 million by 2028 with a CAGR of 2.0% during review period. Hospital Pharmacy accounting for % of the Antihypertensive global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Diuretics segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antihypertensive include Pfizer, Norvatis, Merck & Co., Sanofi, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antihypertensive market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators & Renin Inhibitors
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
The key market players for global Antihypertensive market are listed below:
Pfizer
Norvatis
Merck & Co.
Sanofi
AstraZeneca
GSK
Daiichi-Sankyo
Boehringer-Ingelheim
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Tekeda
Ranbaxy Laboratories
Shihuida Pharm
Second Pharmaceutical
Lupin Limited.
Yangtze River Pharmaceutical
Hengrui Medicine
Qilu Pharmaceutical
HUALON
Dawnrays
HISUN Pharmceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antihypertensive product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antihypertensive, with price, sales, revenue and global market share of Antihypertensive from 2019 to 2022.
Chapter 3, the Antihypertensive competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antihypertensive breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antihypertensive market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antihypertensive.
Chapter 13, 14, and 15, to describe Antihypertensive sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antihypertensive Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Diuretics
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Angiotensin Receptor Blockers (ARBs)
1.2.5 Calcium Channel Blockers
1.2.6 Beta Blockers
1.2.7 Alpha Blockers
1.2.8 Vasodilators & Renin Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Antihypertensive Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Antihypertensive Market Size & Forecast
1.4.1 Global Antihypertensive Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antihypertensive Sales in Volume (2017-2028)
1.4.3 Global Antihypertensive Price (2017-2028)
1.5 Global Antihypertensive Production Capacity Analysis
1.5.1 Global Antihypertensive Total Production Capacity (2017-2028)
1.5.2 Global Antihypertensive Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antihypertensive Market Drivers
1.6.2 Antihypertensive Market Restraints
1.6.3 Antihypertensive Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Antihypertensive Product and Services
2.1.4 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Norvatis
2.2.1 Norvatis Details
2.2.2 Norvatis Major Business
2.2.3 Norvatis Antihypertensive Product and Services
2.2.4 Norvatis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck & Co.
2.3.1 Merck & Co. Details
2.3.2 Merck & Co. Major Business
2.3.3 Merck & Co. Antihypertensive Product and Services
2.3.4 Merck & Co. Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Antihypertensive Product and Services
2.4.4 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Antihypertensive Product and Services
2.5.4 AstraZeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Antihypertensive Product and Services
2.6.4 GSK Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Daiichi-Sankyo
2.7.1 Daiichi-Sankyo Details
2.7.2 Daiichi-Sankyo Major Business
2.7.3 Daiichi-Sankyo Antihypertensive Product and Services
2.7.4 Daiichi-Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Boehringer-Ingelheim
2.8.1 Boehringer-Ingelheim Details
2.8.2 Boehringer-Ingelheim Major Business
2.8.3 Boehringer-Ingelheim Antihypertensive Product and Services
2.8.4 Boehringer-Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Antihypertensive Product and Services
2.9.4 Bayer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Antihypertensive Product and Services
2.10.4 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business
2.11.3 Bristol-Myers Squibb Antihypertensive Product and Services
2.11.4 Bristol-Myers Squibb Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Tekeda
2.12.1 Tekeda Details
2.12.2 Tekeda Major Business
2.12.3 Tekeda Antihypertensive Product and Services
2.12.4 Tekeda Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Ranbaxy Laboratories
2.13.1 Ranbaxy Laboratories Details
2.13.2 Ranbaxy Laboratories Major Business
2.13.3 Ranbaxy Laboratories Antihypertensive Product and Services
2.13.4 Ranbaxy Laboratories Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Shihuida Pharm
2.14.1 Shihuida Pharm Details
2.14.2 Shihuida Pharm Major Business
2.14.3 Shihuida Pharm Antihypertensive Product and Services
2.14.4 Shihuida Pharm Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Second Pharmaceutical
2.15.1 Second Pharmaceutical Details
2.15.2 Second Pharmaceutical Major Business
2.15.3 Second Pharmaceutical Antihypertensive Product and Services
2.15.4 Second Pharmaceutical Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Lupin Limited.
2.16.1 Lupin Limited. Details
2.16.2 Lupin Limited. Major Business
2.16.3 Lupin Limited. Antihypertensive Product and Services
2.16.4 Lupin Limited. Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Yangtze River Pharmaceutical
2.17.1 Yangtze River Pharmaceutical Details
2.17.2 Yangtze River Pharmaceutical Major Business
2.17.3 Yangtze River Pharmaceutical Antihypertensive Product and Services
2.17.4 Yangtze River Pharmaceutical Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Hengrui Medicine
2.18.1 Hengrui Medicine Details
2.18.2 Hengrui Medicine Major Business
2.18.3 Hengrui Medicine Antihypertensive Product and Services
2.18.4 Hengrui Medicine Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Qilu Pharmaceutical
2.19.1 Qilu Pharmaceutical Details
2.19.2 Qilu Pharmaceutical Major Business
2.19.3 Qilu Pharmaceutical Antihypertensive Product and Services
2.19.4 Qilu Pharmaceutical Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 HUALON
2.20.1 HUALON Details
2.20.2 HUALON Major Business
2.20.3 HUALON Antihypertensive Product and Services
2.20.4 HUALON Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Dawnrays
2.21.1 Dawnrays Details
2.21.2 Dawnrays Major Business
2.21.3 Dawnrays Antihypertensive Product and Services
2.21.4 Dawnrays Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 HISUN Pharmceutical
2.22.1 HISUN Pharmceutical Details
2.22.2 HISUN Pharmceutical Major Business
2.22.3 HISUN Pharmceutical Antihypertensive Product and Services
2.22.4 HISUN Pharmceutical Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antihypertensive Breakdown Data by Manufacturer
3.1 Global Antihypertensive Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antihypertensive Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antihypertensive
3.4 Market Concentration Rate
3.4.1 Top 3 Antihypertensive Manufacturer Market Share in 2021
3.4.2 Top 6 Antihypertensive Manufacturer Market Share in 2021
3.5 Global Antihypertensive Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antihypertensive Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antihypertensive Market Size by Region
4.1.1 Global Antihypertensive Sales in Volume by Region (2017-2028)
4.1.2 Global Antihypertensive Revenue by Region (2017-2028)
4.2 North America Antihypertensive Revenue (2017-2028)
4.3 Europe Antihypertensive Revenue (2017-2028)
4.4 Asia-Pacific Antihypertensive Revenue (2017-2028)
4.5 South America Antihypertensive Revenue (2017-2028)
4.6 Middle East and Africa Antihypertensive Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antihypertensive Sales in Volume by Type (2017-2028)
5.2 Global Antihypertensive Revenue by Type (2017-2028)
5.3 Global Antihypertensive Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antihypertensive Sales in Volume by Application (2017-2028)
6.2 Global Antihypertensive Revenue by Application (2017-2028)
6.3 Global Antihypertensive Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antihypertensive Sales by Type (2017-2028)
7.2 North America Antihypertensive Sales by Application (2017-2028)
7.3 North America Antihypertensive Market Size by Country
7.3.1 North America Antihypertensive Sales in Volume by Country (2017-2028)
7.3.2 North America Antihypertensive Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antihypertensive Sales by Type (2017-2028)
8.2 Europe Antihypertensive Sales by Application (2017-2028)
8.3 Europe Antihypertensive Market Size by Country
8.3.1 Europe Antihypertensive Sales in Volume by Country (2017-2028)
8.3.2 Europe Antihypertensive Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antihypertensive Sales by Type (2017-2028)
9.2 Asia-Pacific Antihypertensive Sales by Application (2017-2028)
9.3 Asia-Pacific Antihypertensive Market Size by Region
9.3.1 Asia-Pacific Antihypertensive Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antihypertensive Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antihypertensive Sales by Type (2017-2028)
10.2 South America Antihypertensive Sales by Application (2017-2028)
10.3 South America Antihypertensive Market Size by Country
10.3.1 South America Antihypertensive Sales in Volume by Country (2017-2028)
10.3.2 South America Antihypertensive Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antihypertensive Sales by Type (2017-2028)
11.2 Middle East & Africa Antihypertensive Sales by Application (2017-2028)
11.3 Middle East & Africa Antihypertensive Market Size by Country
11.3.1 Middle East & Africa Antihypertensive Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antihypertensive Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antihypertensive and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antihypertensive
12.3 Antihypertensive Production Process
12.4 Antihypertensive Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antihypertensive Typical Distributors
13.3 Antihypertensive Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Antihypertensive Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antihypertensive Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Antihypertensive Product and Services
Table 6. Pfizer Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Norvatis Basic Information, Manufacturing Base and Competitors
Table 8. Norvatis Major Business
Table 9. Norvatis Antihypertensive Product and Services
Table 10. Norvatis Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 12. Merck & Co. Major Business
Table 13. Merck & Co. Antihypertensive Product and Services
Table 14. Merck & Co. Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Antihypertensive Product and Services
Table 18. Sanofi Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Antihypertensive Product and Services
Table 22. AstraZeneca Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK Antihypertensive Product and Services
Table 26. GSK Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table 28. Daiichi-Sankyo Major Business
Table 29. Daiichi-Sankyo Antihypertensive Product and Services
Table 30. Daiichi-Sankyo Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 32. Boehringer-Ingelheim Major Business
Table 33. Boehringer-Ingelheim Antihypertensive Product and Services
Table 34. Boehringer-Ingelheim Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bayer Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Major Business
Table 37. Bayer Antihypertensive Product and Services
Table 38. Bayer Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 40. Johnson & Johnson Major Business
Table 41. Johnson & Johnson Antihypertensive Product and Services
Table 42. Johnson & Johnson Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 44. Bristol-Myers Squibb Major Business
Table 45. Bristol-Myers Squibb Antihypertensive Product and Services
Table 46. Bristol-Myers Squibb Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Tekeda Basic Information, Manufacturing Base and Competitors
Table 48. Tekeda Major Business
Table 49. Tekeda Antihypertensive Product and Services
Table 50. Tekeda Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Ranbaxy Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. Ranbaxy Laboratories Major Business
Table 53. Ranbaxy Laboratories Antihypertensive Product and Services
Table 54. Ranbaxy Laboratories Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Shihuida Pharm Basic Information, Manufacturing Base and Competitors
Table 56. Shihuida Pharm Major Business
Table 57. Shihuida Pharm Antihypertensive Product and Services
Table 58. Shihuida Pharm Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Second Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Second Pharmaceutical Major Business
Table 61. Second Pharmaceutical Antihypertensive Product and Services
Table 62. Second Pharmaceutical Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Lupin Limited. Basic Information, Manufacturing Base and Competitors
Table 64. Lupin Limited. Major Business
Table 65. Lupin Limited. Antihypertensive Product and Services
Table 66. Lupin Limited. Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Yangtze River Pharmaceutical Major Business
Table 69. Yangtze River Pharmaceutical Antihypertensive Product and Services
Table 70. Yangtze River Pharmaceutical Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 72. Hengrui Medicine Major Business
Table 73. Hengrui Medicine Antihypertensive Product and Services
Table 74. Hengrui Medicine Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Qilu Pharmaceutical Major Business
Table 77. Qilu Pharmaceutical Antihypertensive Product and Services
Table 78. Qilu Pharmaceutical Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. HUALON Basic Information, Manufacturing Base and Competitors
Table 80. HUALON Major Business
Table 81. HUALON Antihypertensive Product and Services
Table 82. HUALON Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Dawnrays Basic Information, Manufacturing Base and Competitors
Table 84. Dawnrays Major Business
Table 85. Dawnrays Antihypertensive Product and Services
Table 86. Dawnrays Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. HISUN Pharmceutical Basic Information, Manufacturing Base and Competitors
Table 88. HISUN Pharmceutical Major Business
Table 89. HISUN Pharmceutical Antihypertensive Product and Services
Table 90. HISUN Pharmceutical Antihypertensive Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Global Antihypertensive Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 92. Global Antihypertensive Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 93. Market Position of Manufacturers in Antihypertensive, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 94. Global Antihypertensive Production Capacity by Company, (K Units): 2020 VS 2021
Table 95. Head Office and Antihypertensive Production Site of Key Manufacturer
Table 96. Antihypertensive New Entrant and Capacity Expansion Plans
Table 97. Antihypertensive Mergers & Acquisitions in the Past Five Years
Table 98. Global Antihypertensive Sales by Region (2017-2022) & (K Units)
Table 99. Global Antihypertensive Sales by Region (2023-2028) & (K Units)
Table 100. Global Antihypertensive Revenue by Region (2017-2022) & (USD Million)
Table 101. Global Antihypertensive Revenue by Region (2023-2028) & (USD Million)
Table 102. Global Antihypertensive Sales by Type (2017-2022) & (K Units)
Table 103. Global Antihypertensive Sales by Type (2023-2028) & (K Units)
Table 104. Global Antihypertensive Revenue by Type (2017-2022) & (USD Million)
Table 105. Global Antihypertensive Revenue by Type (2023-2028) & (USD Million)
Table 106. Global Antihypertensive Price by Type (2017-2022) & (USD/Unit)
Table 107. Global Antihypertensive Price by Type (2023-2028) & (USD/Unit)
Table 108. Global Antihypertensive Sales by Application (2017-2022) & (K Units)
Table 109. Global Antihypertensive Sales by Application (2023-2028) & (K Units)
Table 110. Global Antihypertensive Revenue by Application (2017-2022) & (USD Million)
Table 111. Global Antihypertensive Revenue by Application (2023-2028) & (USD Million)
Table 112. Global Antihypertensive Price by Application (2017-2022) & (USD/Unit)
Table 113. Global Antihypertensive Price by Application (2023-2028) & (USD/Unit)
Table 114. North America Antihypertensive Sales by Country (2017-2022) & (K Units)
Table 115. North America Antihypertensive Sales by Country (2023-2028) & (K Units)
Table 116. North America Antihypertensive Revenue by Country (2017-2022) & (USD Million)
Table 117. North America Antihypertensive Revenue by Country (2023-2028) & (USD Million)
Table 118. North America Antihypertensive Sales by Type (2017-2022) & (K Units)
Table 119. North America Antihypertensive Sales by Type (2023-2028) & (K Units)
Table 120. North America Antihypertensive Sales by Application (2017-2022) & (K Units)
Table 121. North America Antihypertensive Sales by Application (2023-2028) & (K Units)
Table 122. Europe Antihypertensive Sales by Country (2017-2022) & (K Units)
Table 123. Europe Antihypertensive Sales by Country (2023-2028) & (K Units)
Table 124. Europe Antihypertensive Revenue by Country (2017-2022) & (USD Million)
Table 125. Europe Antihypertensive Revenue by Country (2023-2028) & (USD Million)
Table 126. Europe Antihypertensive Sales by Type (2017-2022) & (K Units)
Table 127. Europe Antihypertensive Sales by Type (2023-2028) & (K Units)
Table 128. Europe Antihypertensive Sales by Application (2017-2022) & (K Units)
Table 129. Europe Antihypertensive Sales by Application (2023-2028) & (K Units)
Table 130. Asia-Pacific Antihypertensive Sales by Region (2017-2022) & (K Units)
Table 131. Asia-Pacific Antihypertensive Sales by Region (2023-2028) & (K Units)
Table 132. Asia-Pacific Antihypertensive Revenue by Region (2017-2022) & (USD Million)
Table 133. Asia-Pacific Antihypertensive Revenue by Region (2023-2028) & (USD Million)
Table 134. Asia-Pacific Antihypertensive Sales by Type (2017-2022) & (K Units)
Table 135. Asia-Pacific Antihypertensive Sales by Type (2023-2028) & (K Units)
Table 136. Asia-Pacific Antihypertensive Sales by Application (2017-2022) & (K Units)
Table 137. Asia-Pacific Antihypertensive Sales by Application (2023-2028) & (K Units)
Table 138. South America Antihypertensive Sales by Country (2017-2022) & (K Units)
Table 139. South America Antihypertensive Sales by Country (2023-2028) & (K Units)
Table 140. South America Antihypertensive Revenue by Country (2017-2022) & (USD Million)
Table 141. South America Antihypertensive Revenue by Country (2023-2028) & (USD Million)
Table 142. South America Antihypertensive Sales by Type (2017-2022) & (K Units)
Table 143. South America Antihypertensive Sales by Type (2023-2028) & (K Units)
Table 144. South America Antihypertensive Sales by Application (2017-2022) & (K Units)
Table 145. South America Antihypertensive Sales by Application (2023-2028) & (K Units)
Table 146. Middle East & Africa Antihypertensive Sales by Region (2017-2022) & (K Units)
Table 147. Middle East & Africa Antihypertensive Sales by Region (2023-2028) & (K Units)
Table 148. Middle East & Africa Antihypertensive Revenue by Region (2017-2022) & (USD Million)
Table 149. Middle East & Africa Antihypertensive Revenue by Region (2023-2028) & (USD Million)
Table 150. Middle East & Africa Antihypertensive Sales by Type (2017-2022) & (K Units)
Table 151. Middle East & Africa Antihypertensive Sales by Type (2023-2028) & (K Units)
Table 152. Middle East & Africa Antihypertensive Sales by Application (2017-2022) & (K Units)
Table 153. Middle East & Africa Antihypertensive Sales by Application (2023-2028) & (K Units)
Table 154. Antihypertensive Raw Material
Table 155. Key Manufacturers of Antihypertensive Raw Materials
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Antihypertensive Typical Distributors
Table 159. Antihypertensive Typical Customers
List of Figures
Figure 1. Antihypertensive Picture
Figure 2. Global Antihypertensive Revenue Market Share by Type in 2021
Figure 3. Diuretics
Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors
Figure 5. Angiotensin Receptor Blockers (ARBs)
Figure 6. Calcium Channel Blockers
Figure 7. Beta Blockers
Figure 8. Alpha Blockers
Figure 9. Vasodilators & Renin Inhibitors
Figure 10. Global Antihypertensive Revenue Market Share by Application in 2021
Figure 11. Hospital Pharmacy
Figure 12. Retail Pharmacy
Figure 13. Online Pharmacy
Figure 14. Others
Figure 15. Global Antihypertensive Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Antihypertensive Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Antihypertensive Sales (2017-2028) & (K Units)
Figure 18. Global Antihypertensive Price (2017-2028) & (USD/Unit)
Figure 19. Global Antihypertensive Production Capacity (2017-2028) & (K Units)
Figure 20. Global Antihypertensive Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Antihypertensive Market Drivers
Figure 22. Antihypertensive Market Restraints
Figure 23. Antihypertensive Market Trends
Figure 24. Global Antihypertensive Sales Market Share by Manufacturer in 2021
Figure 25. Global Antihypertensive Revenue Market Share by Manufacturer in 2021
Figure 26. Antihypertensive Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Antihypertensive Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Antihypertensive Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Antihypertensive Sales Market Share by Region (2017-2028)
Figure 30. Global Antihypertensive Revenue Market Share by Region (2017-2028)
Figure 31. North America Antihypertensive Revenue (2017-2028) & (USD Million)
Figure 32. Europe Antihypertensive Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Antihypertensive Revenue (2017-2028) & (USD Million)
Figure 34. South America Antihypertensive Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Antihypertensive Revenue (2017-2028) & (USD Million)
Figure 36. Global Antihypertensive Sales Market Share by Type (2017-2028)
Figure 37. Global Antihypertensive Revenue Market Share by Type (2017-2028)
Figure 38. Global Antihypertensive Price by Type (2017-2028) & (USD/Unit)
Figure 39. Global Antihypertensive Sales Market Share by Application (2017-2028)
Figure 40. Global Antihypertensive Revenue Market Share by Application (2017-2028)
Figure 41. Global Antihypertensive Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Antihypertensive Sales Market Share by Type (2017-2028)
Figure 43. North America Antihypertensive Sales Market Share by Application (2017-2028)
Figure 44. North America Antihypertensive Sales Market Share by Country (2017-2028)
Figure 45. North America Antihypertensive Revenue Market Share by Country (2017-2028)
Figure 46. United States Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Antihypertensive Sales Market Share by Type (2017-2028)
Figure 50. Europe Antihypertensive Sales Market Share by Application (2017-2028)
Figure 51. Europe Antihypertensive Sales Market Share by Country (2017-2028)
Figure 52. Europe Antihypertensive Revenue Market Share by Country (2017-2028)
Figure 53. Germany Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Antihypertensive Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Antihypertensive Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Antihypertensive Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Antihypertensive Revenue Market Share by Region (2017-2028)
Figure 62. China Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Antihypertensive Sales Market Share by Type (2017-2028)
Figure 69. South America Antihypertensive Sales Market Share by Application (2017-2028)
Figure 70. South America Antihypertensive Sales Market Share by Country (2017-2028)
Figure 71. South America Antihypertensive Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Antihypertensive Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Antihypertensive Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Antihypertensive Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Antihypertensive Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Antihypertensive Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Antihypertensive in 2021
Figure 83. Manufacturing Process Analysis of Antihypertensive
Figure 84. Antihypertensive Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source
